Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-009572
Filing Date
2025-12-01
Accepted
2025-12-01 16:37:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5434
  Complete submission text file 0001950047-25-009572.txt   6849
Mailing Address 6055 LUSK BLVD. SAN DIEGO CA 92121
Business Address 6055 LUSK BLVD. SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Subject) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38583 | Film No.: 251540151
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD SAN DIEGO CA 92121
Business Address
Pizzuti Dana (Reporting) CIK: 0001948238 (see all company filings)

Type: 144